Navigation Links
U.S. Doctors’ Clinical Announces Expanded Distribution of Biotix Plus® at Walgreens
Date:7/3/2017

U.S. Doctors’ Clinical® is excited to announce today that it has received the first order of Biotix Plus® synergistic probiotic dietary supplement from Walgreens, and expects to begin shipping on July 3, 2017.

“We are very excited about the launch of Biotix Plus®, which will be available in select Walgreens stores beginning this summer. This marks a major milestone in the development and growth of the U.S. Doctors’ Clinical® brand. By adding a new probiotic supplement and significantly expanding distribution within Walgreens store footprint, we expect significant revenue and earnings growth in the coming quarters," said Tom Nguyen, CEO and Founder of the U.S. Doctors’ Clinical® brand.

Digestive issues continue to be a major source of discomfort and inconvenience for a large number of individuals. Biotix Plus® delivers 24/7 digestive support, intestinal protection against harmful bacteria, and supports immune system function with a combination of clinically studied, trademarked prebiotic and probiotic strains. These clinically studied ingredients work synergistically to build up the good bacteria in your intestines and colon, where you really need it – pushing out bad bacteria, helping the body digest food properly, aiding in nutrient absorption and even toxin disposal.

Biotix Plus® is available in high absorption, easy-to-swallow softgels that are shelf-stable for up to two years and require NO refrigeration. Walgreens will carry the 60-count bottle at the suggested retail price of $39.99 per unit.

U.S. Doctors’ Clinical® products are also available at Rite Aid, Kmart, Wegmans Food Market, and other online retailers. For more information, please visit http://www.usdoctorsclinical.com.

About U.S. Doctors’ Clinical®

U.S. Doctors’ Clinical® is a premium supplement line that features both doctor-recommend and doctor-formulated products for a range of health areas. Each product contains high-quality nutrients that delivers maximum purity and effectiveness, and made to the standards of professional doctors and healthcare practitioners. All USDC products have undergone rigorous testing with results featured in numerous prestigious journals and publications.

U.S. Doctors’ Clinical® additionally features supplements in several delivery forms for customer preference and convenience, including highly absorbable softgels, capsules, and tablets, as well as a specialty vegetarian softgels line that contain no animal sources, are non-gmo, gluten-free, and are appropriate for vegans. All products are produced by a USA-based manufacturer that is fully-certified for several third-party certifications (NPA, NFS, UL and CCOF) upholds cGMP practices, and uses the latest in advanced supplement technology.

See the Company's web site at http://www.usdoctorsclinical.com for additional product information or email Public_Relations(at)usdoctorsclinical(dot)com.

About Our New Retail Partner

Walgreens (http://www.walgreens.com), one of the nation's largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc., the first global pharmacy-led, health and wellbeing enterprise. More than 10 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,175 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, along with its omnichannel business, Walgreens.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services. For more information on Walgreens, visit http://www.walgreens.com.

Forward Looking Statements

This press release includes statements, which may constitute forward looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors which would cause or contribute to such differences include, but are not limited to competition from existing or new products, production delays, lack of market acceptance of the Company's products, the Company's ability to develop acceptable sales and marketing relationships, the Company's ability to generate necessary capital, and general economic conditions and such other factors as are detailed in the Company's Securities and Exchange Commission filings.

  • These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
  • Biotix Plus is a registered trademark of U.S. Doctors’ Clinical. All rights reserved

Read the full story at http://www.prweb.com/releases/USDC/BiotixPlus/prweb14467567.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Dr. Monali Misra of Beverly Hills Physicians Wins the 2016 Los Angeles Doctors’ Choice Award for Bariatric Surgery
2. ‘Best Doctors’ Issue of New York Magazine Includes Dr. Robert M. Bernstein, Hair Transplant Pioneer, for Sixteenth Consecutive Year
3. Wimbledon Health Partners Recognizes National Doctors’ Day
4. Harbor Village Detox Asserts the Drug Enforcement Administration Is Limiting Doctors’ Abilities to Treat Drug Addiction
5. The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries
6. Healthspek Users Can Now Import Their Doctors’ Records into Their Personal Health Record
7. The Pennsylvania Athletic Trainers’ Society (PATS) Holds Its Annual Meeting and Clinical Symposium in Erie, PA
8. AMC Health Continues to Expand Its Success of Telehealth in Clinical Trials
9. Intrinsic Clinical Systems to Attend DIA Annual Meeting in Chicago, Illinois
10. Bioclinica Launches Clean Patient Optics to Accelerate Database Lock and Clinical Trial Timelines
11. CISCRP Supports Lilly’s Hero’s Journey Art Project to Honor Clinical Trial Participants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... at the University of California Berkeley, and other leading institutions in announcing the ... power of institutions to change the way animals are raised for food. , ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
(Date:10/4/2017)... 2017  South Korean-based healthcare product Development Company I.M. ... on Kickstarter. The device will educate the user about ... better efficiency compared to the dated and pricey CPR ... efficacy of the compression for a more informed CPR ... to raise $5,000. ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
Breaking Medicine Technology: